Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Item
http://www.wikidata.org/entity/Q38219529
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamWhat amyloid ligands can tell us about molecular polymorphism and disease.Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.Imaging Alzheimer's disease pathophysiology with PET.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic reviewMagnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
P2860

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Item
http://www.wikidata.org/entity/Q38219529
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Use of amyloid PET across the ...... and associated ethical issues.
@en
type
label
Use of amyloid PET across the ...... and associated ethical issues.
@en
prefLabel
Use of amyloid PET across the ...... and associated ethical issues.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Use of amyloid PET across the ...... and associated ethical issues.
@en
P2093
P2860
P304
P31
P356
10.3109/13506129.2014.926267
P433
P478
P50
P577
P698
P921